R01 AI102618/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2013	1
2014	3
2015	2
2016	1
2017	4
2018	1
2019	2
2020	1
2021	1
2022	1
2023	1
2024	0

1

Exploiting fungal cell wall components in vaccines.

Levitz SM, Huang H, Ostroff GR, Specht CA. Levitz SM, et al. Semin Immunopathol. 2015 Mar;37(2):199-207. doi: 10.1007/s00281-014-0460-6. Epub 2014 Nov 18. Semin Immunopathol. 2015. PMID: 25404118 Free PMC article. Review.

2

Aspergillus vaccines: Hardly worth studying or worthy of hard study?

Levitz SM. Levitz SM. Med Mycol. 2017 Jan 1;55(1):103-108. doi: 10.1093/mmy/myw081. Epub 2016 Sep 17. Med Mycol. 2017. PMID: 27639242 Free PMC article. Review.

3

Modulating host immune responses to fight invasive fungal infections.

Scriven JE, Tenforde MW, Levitz SM, Jarvis JN. Scriven JE, et al. Curr Opin Microbiol. 2017 Dec;40:95-103. doi: 10.1016/j.mib.2017.10.018. Epub 2017 Nov 15. Curr Opin Microbiol. 2017. PMID: 29154044 Free PMC article. Review.

4

Spectrum and mechanisms of inflammasome activation by chitosan.

Bueter CL, Lee CK, Wang JP, Ostroff GR, Specht CA, Levitz SM. Bueter CL, et al. J Immunol. 2014 Jun 15;192(12):5943-51. doi: 10.4049/jimmunol.1301695. Epub 2014 May 14. J Immunol. 2014. PMID: 24829412 Free PMC article.

5

A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens.

Abraham A, Ostroff G, Levitz SM, Oyston PCF. Abraham A, et al. Clin Exp Immunol. 2019 Nov;198(2):143-152. doi: 10.1111/cei.13356. Epub 2019 Sep 12. Clin Exp Immunol. 2019. PMID: 31400225 Free PMC article. Review.

6

Protection of Mice against Experimental Cryptococcosis by Synthesized Peptides Delivered in Glucan Particles.

Specht CA, Homan EJ, Lee CK, Mou Z, Gomez CL, Hester MM, Abraham A, Rus F, Ostroff GR, Levitz SM. Specht CA, et al. mBio. 2021 Feb 22;13(1):e0336721. doi: 10.1128/mbio.03367-21. Epub 2022 Jan 4. mBio. 2021. PMID: 35089095 Free PMC article.

7

Immunological correlates of protection following vaccination with glucan particles containing Cryptococcus neoformans chitin deacetylases.

Wang R, Oliveira LVN, Lourenco D, Gomez CL, Lee CK, Hester MM, Mou Z, Ostroff GR, Specht CA, Levitz SM. Wang R, et al. NPJ Vaccines. 2023 Feb 2;8(1):6. doi: 10.1038/s41541-023-00606-0. NPJ Vaccines. 2023. PMID: 36732332 Free PMC article.

8

Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.

Hester MM, Lee CK, Abraham A, Khoshkenar P, Ostroff GR, Levitz SM, Specht CA. Hester MM, et al. Vaccine. 2020 Jan 16;38(3):620-626. doi: 10.1016/j.vaccine.2019.10.051. Epub 2019 Nov 4. Vaccine. 2020. PMID: 31699504 Free PMC article.

9

Characterization and optimization of the glucan particle-based vaccine platform.

Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM. Huang H, et al. Clin Vaccine Immunol. 2013 Oct;20(10):1585-91. doi: 10.1128/CVI.00463-13. Epub 2013 Aug 14. Clin Vaccine Immunol. 2013. PMID: 23945157 Free PMC article.

10

Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.

Specht CA, Lee CK, Huang H, Tipper DJ, Shen ZT, Lodge JK, Leszyk J, Ostroff GR, Levitz SM. Specht CA, et al. mBio. 2015 Dec 22;6(6):e01905-15. doi: 10.1128/mBio.01905-15. mBio. 2015. PMID: 26695631 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year